Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Enzo Biochem stock | $3.31

Learn how to easily invest in Enzo Biochem stock.

Enzo Biochem Inc is a diagnostics & research business based in the US. Enzo Biochem shares (ENZ) are listed on the NYSE and all prices are listed in US Dollars.

How to buy shares in Enzo Biochem

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ENZ – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Enzo Biochem stock price (NYSE: ENZ)

Use our graph to track the performance of ENZ stocks over time.

Enzo Biochem shares at a glance

Information last updated 2021-10-16.
Latest market close$3.31
52-week range$1.80 - $4.15
50-day moving average $3.64
200-day moving average $3.28
Wall St. target price$5.50
PE ratio 140
Dividend yield N/A (0%)
Earnings per share (TTM) $0.03

Buy Enzo Biochem shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Enzo Biochem stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Enzo Biochem price performance over time

Historical closes compared with the close of $3.31 from 2021-10-22

1 week (2021-10-15) -12.43%
1 month (2021-09-23) -8.56%
3 months (2021-07-23) 5.75%
6 months (2021-04-23) 1.53%
1 year (2020-10-23) 57.62%
2 years (2019-10-23) 3.44%
3 years (2018-10-23) 3.36
5 years (2016-10-21) 5.93

Is Enzo Biochem under- or over-valued?

Valuing Enzo Biochem stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Enzo Biochem's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Enzo Biochem's P/E ratio

Enzo Biochem's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 140x. In other words, Enzo Biochem shares trade at around 140x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Enzo Biochem's EBITDA

Enzo Biochem's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.4 million.

The EBITDA is a measure of a Enzo Biochem's overall financial performance and is widely used to measure a its profitability.

Enzo Biochem financials

Revenue TTM $112.4 million
Gross profit TTM $23.8 million
Return on assets TTM -0.09%
Return on equity TTM 2.01%
Profit margin 1.14%
Book value $1.34
Market capitalisation $183.2 million

TTM: trailing 12 months

Shorting Enzo Biochem shares

There are currently 623,668 Enzo Biochem shares held short by investors – that's known as Enzo Biochem's "short interest". This figure is 6% up from 588,216 last month.

There are a few different ways that this level of interest in shorting Enzo Biochem shares can be evaluated.

Enzo Biochem's "short interest ratio" (SIR)

Enzo Biochem's "short interest ratio" (SIR) is the quantity of Enzo Biochem shares currently shorted divided by the average quantity of Enzo Biochem shares traded daily (recently around 79651.085568327). Enzo Biochem's SIR currently stands at 7.83. In other words for every 100,000 Enzo Biochem shares traded daily on the market, roughly 7830 shares are currently held short.

However Enzo Biochem's short interest can also be evaluated against the total number of Enzo Biochem shares, or, against the total number of tradable Enzo Biochem shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Enzo Biochem's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Enzo Biochem shares in existence, roughly 10 shares are currently held short) or 0.0202% of the tradable shares (for every 100,000 tradable Enzo Biochem shares, roughly 20 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Enzo Biochem.

Find out more about how you can short Enzo Biochem stock.

Enzo Biochem share dividends

We're not expecting Enzo Biochem to pay a dividend over the next 12 months.

Have Enzo Biochem's shares ever split?

Enzo Biochem's shares were split on a 105:100 basis on 20 October 2004. So if you had owned 100 shares the day before before the split, the next day you'd have owned 105 shares. This wouldn't directly have changed the overall worth of your Enzo Biochem shares – just the quantity. However, indirectly, the new 4.8% lower share price could have impacted the market appetite for Enzo Biochem shares which in turn could have impacted Enzo Biochem's share price.

Enzo Biochem share price volatility

Over the last 12 months, Enzo Biochem's shares have ranged in value from as little as $1.8 up to $4.15. A popular way to gauge a stock's volatility is its "beta".

ENZ.US volatility(beta: 0.84)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Enzo Biochem's is 0.8418. This would suggest that Enzo Biochem's shares are less volatile than average (for this exchange).

Enzo Biochem overview

Enzo Biochem, Inc. , an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also provides its products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment provides molecular and other clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition.

Frequently asked questions

What percentage of Enzo Biochem is owned by insiders or institutions?
Currently 19.698% of Enzo Biochem shares are held by insiders and 50.007% by institutions.
When does the fiscal year end for Enzo Biochem?
Enzo Biochem's fiscal year ends in July.
Where is Enzo Biochem based?
Enzo Biochem's address is: 527 Madison Avenue, New York, NY, United States, 10022
What is Enzo Biochem's ISIN number?
Enzo Biochem's international securities identification number is: US2941001024
What is Enzo Biochem's CUSIP number?
Enzo Biochem's Committee on Uniform Securities Identification Procedures number is: 294100102

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site